Chris obtained a BSc and a MSc in Molecular Biology from the University of Applied Science Gelsenkirchen. During and in between his studies he worked for Artemis Pharmaceuticals generating novel and innovative RNAi-based gene targeting in mice. Chris performed his Master thesis in the Cell Signalling lab of Prof. Bart Vanhaesebroeck at QMUL London, working on distinct roles of Class IA PI3K isoforms in angiogenesis. He subsequently became a fellow of the Berlin-Brandenburg School for Regenerative Therapies (BSRT, DFG Graduate School 203) and joined the Lab of Prof. Petra Knaus in October 2008. Chris completed his PhD in November 2013 with the title “BMP2-induced PI3K signalling in directional cell migration – from molecular pathway to cellular function-“ with summa cum laude.
His current aim as postdoctoral researcher (BSRT associated Postdoctoral Fellow) is to understand the crosstalk of BMP signalling and mechanotransduction using advanced light-microscopy techniques.
Chris is member of the German Society of Cell Biology (DGZ) as well as Gesellschaft deutscher Chemiker (GDCh)